|
BIO-CAT Inc
hus1 shrna lentiviral non-target control constructs ![]() Hus1 Shrna Lentiviral Non Target Control Constructs, supplied by BIO-CAT Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/shrna+construct/hus1+shrna+lentiviral+non+target+control+constructs/pmc11384956-136-0-8 Average 90 stars, based on 1 article reviews
hus1 shrna lentiviral non-target control constructs - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Broad Institute Inc
plasmid /lentivirus constructs plko-shrnas for gopc ![]() Plasmid /Lentivirus Constructs Plko Shrnas For Gopc, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/shrna+construct/plasmid++lentivirus+constructs+plko+shrnas+for+gopc/pmc04414737-45-5-11 Average 90 stars, based on 1 article reviews
plasmid /lentivirus constructs plko-shrnas for gopc - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Broad Institute Inc
shrna constructs ![]() Shrna Constructs, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/shrna+construct/shrna+constructs/pmc06886683__NIHMS1544229___supplement___3-321-1-7 Average 90 stars, based on 1 article reviews
shrna constructs - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GenScript corporation
shrna vectors ![]() Shrna Vectors, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/shrna+construct/shrna+constructs/pmc05419284-293-1-21 Average 90 stars, based on 1 article reviews
shrna vectors - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Broad Institute Inc
lal shrna construct trcn0000029245 ![]() Lal Shrna Construct Trcn0000029245, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/shrna+construct/lal+shrna+construct+trcn0000029245/pmc06528899-95-7-18 Average 90 stars, based on 1 article reviews
lal shrna construct trcn0000029245 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Macrogen
shp2 shrna construct ![]() Shp2 Shrna Construct, supplied by Macrogen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/shrna+construct/shp2+shrna+construct/10__1194_slash_jlr__m015552-111-2-11 Average 90 stars, based on 1 article reviews
shp2 shrna construct - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Genechem
pxr shrna construct ![]() Pxr Shrna Construct, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/shrna+construct/pxr+shrna+construct/10__1039_slash_c4tx00239c-56-28-34 Average 90 stars, based on 1 article reviews
pxr shrna construct - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Genechem
lentiviral vectors lv-gv369-mir10b-egfp ![]() Lentiviral Vectors Lv Gv369 Mir10b Egfp, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/shrna+construct/lentiviral+particles+containing+prr15+shrna+sequence++in+gv369+construct/pm30504727-84-16-19 Average 90 stars, based on 1 article reviews
lentiviral vectors lv-gv369-mir10b-egfp - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Shanghai Genechem Ltd
shrna constructs prs-shfak/cyclin d1 ![]() Shrna Constructs Prs Shfak/Cyclin D1, supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/shrna+construct/shrna+constructs+prs+shfak+cyclin+d1/pmc05851971-167-13-21 Average 90 stars, based on 1 article reviews
shrna constructs prs-shfak/cyclin d1 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Applied Biological Materials Inc
shrna constructs targeting qr2 ![]() Shrna Constructs Targeting Qr2, supplied by Applied Biological Materials Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/shrna+construct/shrna+constructs+targeting+qr2/pmc07643296-472-37-58 Average 90 stars, based on 1 article reviews
shrna constructs targeting qr2 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Mirimus Inc
shrna constructs ![]() Shrna Constructs, supplied by Mirimus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/shrna+construct/shrna+constructs/pmc06221994-639-15-8 Average 90 stars, based on 1 article reviews
shrna constructs - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Vigene Biosciences
fli-1 shrna construct (fli-1 shrna) ![]() Fli 1 Shrna Construct (Fli 1 Shrna), supplied by Vigene Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/shrna+construct/fli+1+shrna+construct++fli+1+shrna+/pm30387554-222-1-12 Average 90 stars, based on 1 article reviews
fli-1 shrna construct (fli-1 shrna) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cell Reports Medicine
Article Title: Myeloid cells coordinately induce glioma cell-intrinsic and cell-extrinsic pathways for chemoresistance via GP130 signaling
doi: 10.1016/j.xcrm.2024.101658
Figure Lengend Snippet: Humanin-induced chemoresistance requires ATR signaling (A) hGBM1 cells were stimulated with HN or vehicle (Ctrl.), underwent transcriptomics, and differentially expressed genes (DEGs) were analyzed by bioinformatics. (B) Experiments described in (A) were repeated with hGBM-1, 2, and 3 cells providing 12 consistent DEGs, of which several components assembled in a network. (C) HUS1 was associated with outcome in human GBMs. (D) In a myeloid-free brain sample, hGBMs have a basal level of HUS1 expression, which is upregulated by interaction with hiPSC microglia in a GP130-dependent manner. (E and F) Contribution of the ATR pathway to humanin-induced GBM expansion (E) and chemoresistance (F) was demonstrated with the ATR inhibitor AZ20. (G) Western blots showing expression levels of HUS1, ATR and beta-actin (loading control) and a readout for of ATR activation (pT1989) in hGBM1 cells treated with bovine serum albumin (control), TMZ, HN, or AZ20. (H) In summary, AZ20 does not cooperate with TMZ per se, but blocks HN-induced TMZ resistance. The number of biological replicates is indicated (dots in graphs indicate data from individual experiments); all error bars are presented as mean ± SDM. Statistical significance is shown as FDR in (A), one-way ANOVA (D, E), or two-way ANOVA (F): ∗ p < 0.05; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; NS, not significant.
Article Snippet:
Techniques: Expressing, Western Blot, Control, Activation Assay
Journal: Cell Reports Medicine
Article Title: Myeloid cells coordinately induce glioma cell-intrinsic and cell-extrinsic pathways for chemoresistance via GP130 signaling
doi: 10.1016/j.xcrm.2024.101658
Figure Lengend Snippet: Humanin-induced chemoresistance can be blocked therapeutically (A) Tumor size of orthotopic HN-WT or HN-C8a tumors was compared in mice receiving TMZ or vehicle (in animals with established tumor growth, 5x per week for 2 weeks; pre-defined endpoint was at 3 weeks). (B) Orthotopic hGBM1 was infused with HN (100 nM) or vehicle (artificial cerebrospinal fluid, aCSF) and i.p. injected with bazedoxifene-A (5 injections of BZA per week; 40 mg/kg; for 2 weeks) or vehicle; brains were labeled for HUS1; HUS1 expression was quantified. (C) Mice with established, orthotopic HN-WT tumors received TMZ (50 mg/kg) and were cotreated with vehicle or BZA (as in B); after 3 weeks, tumor size was quantified (dashed line: average data from untreated WT GBMs). (D) Mice with HN-WT GBMs received TMZ and were cotreated with vehicle or BZA (as in C); GBM samples were immunostained for active caspase-3 and immunolabeling was quantified (dashed line: average data from untreated WT GBMs). (E) Intratumoral vascularization and vessel diameter were compared in HN-WT or HN-C8a tumors receiving TMZ. (F) The HN-WT GBM mouse model was i.p. injected with TMZ and cotreated either with BZA or vehicle and the extent of intratumoral vascularization was compared. The number of biological replicates is indicated (dots in graphs indicate data from individual mice); all error bars are presented as mean ± SDM. Statistical significance is shown by one-way ANOVA (A, E), two-way ANOVA (B–D), or t test (F): ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant. Scale bars in (B, C) indicate 1 mm; scales in (D) represent 500 (overview) or 10 μm (magnified).
Article Snippet:
Techniques: Injection, Labeling, Expressing, Immunolabeling
Journal: Cell Reports Medicine
Article Title: Myeloid cells coordinately induce glioma cell-intrinsic and cell-extrinsic pathways for chemoresistance via GP130 signaling
doi: 10.1016/j.xcrm.2024.101658
Figure Lengend Snippet:
Article Snippet:
Techniques: Plasmid Preparation, Recombinant, Transfection, Fluorescence, Staining, Reverse Transcription, Expressing, Liposomes, Mutagenesis, shRNA, Control, Construct, Software, Imaging, Functional Assay, Dissection, Sequencing, Real-time Polymerase Chain Reaction
Journal: The Journal of Neuroscience
Article Title: Dopamine-Dependent QR2 Pathway Activation in CA1 Interneurons Enhances Novel Memory Formation
doi: 10.1523/JNEUROSCI.1243-20.2020
Figure Lengend Snippet: QR2 inhibition or reduced expression in CA1 improves TFC memory. a, Mice underwent TFC, which involves 5 min exploration followed by 10 trials in which a tone is applied for 10 s, followed by a footshock 20 s later and an intertrial interval of 3.5 min. b, Mice were killed 3 or 6 h following TFC, and QR2 mRNA levels were measured and compared with mice that were kept in their familiar home cages. Mice that experienced TFC showed a significant reduction in QR2 mRNA expression in CA1 only 3 h later (Naive 1.011 ± 0.069 2-ΔΔCt, n = 5; 3 h TFC 0.657 ± 0.025 2−ΔΔCt, n = 4; 6 h TFC 1.046 ± 0.023 2−ΔΔCt; one-way ANOVA, F(2,11) = 18.7, p = 0.0003; Tukey's multiple comparisons post hoc test, Naive vs 3 h TFC, p = 0.0009; Naive vs 6 h TFC, p = 0.851; 3 h TFC vs 6 h TFC, p = 0.0004). c, Mice were injected with a lentivirus-expressing shRNA targeting QR2 mRNA or a scrambled control to CA1 and underwent TFC. d, Mice receiving shRNA directed against QR2 showed significantly better contextual memory, indicated by the increased freezing (Scrambled 23.36 ± 3.975%, n = 12; QR2 shRNA 38.41 ± 4.471%, n = 12; Mann–Whitney test, p = 0.0068). e, Mice injected with shRNA to QR2 displayed better memory to the cue (Scrambled 20.39 ± 2.76%, n = 12; QR2 shRNA 36.85 ± 5.474%, n = 12; Student's t test, t = 2.685, df = 22, p = 0.0135) and trace (Scrambled 36.41 ± 5.179%, n = 12; QR2 shRNA 52.04 ± 4.942%, n = 12; Mann–Whitney test, p = 0.0145), compared with controls. f, Mice were cannulated to CA1 and were given QR2 inhibitor S29434 (36 μm) or vehicle and 20 min later underwent TFC. g, Cannula placement in mice undergoing TFC with S29434 or vehicle control. h, Mice that received S29434 froze significantly more than those receiving vehicle, displaying improved contextual memory (Vehicle 25.46 ± 2.128%, n = 8; S29434 37.73 ± 3.22%, n = 12; Student's t test, t = 2.83, df = 18, p = 0.0111). i, Cue and trace induced significantly greater freezing in mice receiving S29434, indicating improved memory (Cue test, Vehicle 28.02 ± 2.905%, n = 8; S29434 41.79 ± 3.395%, n = 12; Student's t test, t = 2.865, df = 18, p = 0.0103; Trace test, Vehicle 36.97 ± 3.196%, n = 8; S29434 50.49 ± 3.338%, n = 12; Student's t test, t = 2.78, df = 18, p = 0.0123). j, Mice injected with S29434 show a significant reduction in Kv2.1 channel oxidation compared with vehicle controls (left, Vehicle 1 ± 0.037 AU, n = 10; S29434 0.897 ± 0.041 AU, n = 11; Mann–Whitney test, p = 0.0357), as measured by nonreduced Western blot (right, top; i = S29434; v = Vehicle) and confirmed following addition of reducing agent β-mercaptoethanol (right, bottom). Data are mean ± SEM. *p < 0.05. **p < 0.01. ***p < 0.001.
Article Snippet: Transient cotransfection of four endotoxin-free plasmids (Endo Free plasmid Maxi kit, catalog #12362, QIAGEN) in HEK293FT (Invitrogen) cells produced self-inactivating, third-generation HIV-1-based viral vectors ( Tiscornia et al., 2006 ). pLenti-miR182-GFP and pLenti-control-GFP, as well as short
Techniques: Inhibition, Expressing, Injection, shRNA, Control, MANN-WHITNEY, Western Blot
Journal: The Journal of Neuroscience
Article Title: Dopamine-Dependent QR2 Pathway Activation in CA1 Interneurons Enhances Novel Memory Formation
doi: 10.1523/JNEUROSCI.1243-20.2020
Figure Lengend Snippet: Novelty of the context reduces QR2 expression via miR-182 upregulation. a, Mice were taken from their home cage to a novel cage for 15 min, and were then returned to the familiar home cage and killed either 1 or 3 h later. b, Mice exposed to the novel cage and killed 3 h later showed significantly reduced QR2 mRNA expression in CA1 (Familiar Context 1.003 ± 0.011 2−ΔΔCt, n = 4; 3 h Novel Context 0.613 ± 0.011 2−ΔΔCt, n = 7; Student's t test, t = 11.33, df = 9, p < 0.0001). c, Mice exposed to the novel cage and killed 1 h later showed significantly increased miR-182 levels in CA1 (Familiar Context 1.035 ± 0.132 2−ΔΔCt, n = 5; 1 h Novel Context 4.978 ± 0.403 2−ΔΔCt, n = 7; Student's t test, t = 7.941, df = 10, p < 0.0001). d, A lentivirus-expressing miR-182 and a GFP reporter, or GFP alone, was made and injected to CA1. e, The miR-182 and GFP-injected mice underwent delay conditioning. f, Contextual memory was significantly improved in mice over expressing miR-182 in CA1 compared with controls (Lenti-GFP 27.32 ± 5.772%, n = 4; Lenti-miR-182 53.1 ± 7.541%, n = 5; Student's t test, t = 2.593, df = 7, p = 0.0358). g, No difference was seen in the freezing of mice over expressing miR-182 compared with controls in response to the cue (Lenti-GFP 30.39 ± 3.845%, n = 4; Lenti-miR-182 36.29 ± 8.163%, n = 5; Student's t test, t = 0.5989, df = 7, p = 0.5681). h, CA1 of mice injected with miR-182 expressed significantly greater levels of miR-182 compared with controls (Lenti-GFP 1.119 ± 0.340 2−ΔΔCt, n = 4; Lenti-miR-182 173.4 ± 59.15 2−ΔΔCt, n = 5; Mann–Whitney test, p = 0.015). i, QR2 mRNA expression was significantly reduced in the CA1 of miR-182 injected mice (Lenti-GFP 1.002 ± 0.035 2−ΔΔCt, n = 4; Lenti-miR-182 0.761 ± 0.066 2−ΔΔCt, n = 5; Student's t test, t = 2.958, df = 7, p = 0.0212). Data are mean ± SEM. *p < 0.05. ****p < 0.0001.
Article Snippet: Transient cotransfection of four endotoxin-free plasmids (Endo Free plasmid Maxi kit, catalog #12362, QIAGEN) in HEK293FT (Invitrogen) cells produced self-inactivating, third-generation HIV-1-based viral vectors ( Tiscornia et al., 2006 ). pLenti-miR182-GFP and pLenti-control-GFP, as well as short
Techniques: Expressing, Injection, MANN-WHITNEY
Journal: The Journal of Neuroscience
Article Title: Dopamine-Dependent QR2 Pathway Activation in CA1 Interneurons Enhances Novel Memory Formation
doi: 10.1523/JNEUROSCI.1243-20.2020
Figure Lengend Snippet: QR2 reduced expression following novel context is D1R- and not D2R- or mAChR-dependent. a, Mice were familiarized to intraperitoneal injections, and then were injected scopolamine, eticlopride, SCH, or vehicle. After 40 min, the animals were taken to a novel cage, except one of two groups receiving vehicle. Following 15 min in the novel cage, the animals were returned to their familiar home cages and were killed either 1 or 3 h later to allow QR2 mRNA or miR-182 measurement in CA1. b, QR2 mRNA was significantly reduced in CA1 of mice that received scopolamine or vehicle that were exposed to the novel cage, compared with the control mice kept in familiar home cage (Familiar 1 ± 0.012 2−ΔΔCt, n = 5; Novel/Vehicle 0.859 ± 0.018 2−ΔΔCt, n = 5; Novel/Scopolamine 0.861 ± 0.02 2−ΔΔCt, n = 5; Kruskal–Wallis test, p = 0.0029; Dunn's multiple comparisons test, Familiar vs Novel/Vehicle, p = 0.0216; Familiar vs Novel/Scopolamine, p = 0.0267; Novel/Vehicle vs Novel/Scopolamine, p > 0.9999). c, QR2 mRNA expression reduction following novel cage was seen in mice that received eticlopride or vehicle, but not SCH, compared with control home cage mice (Familiar 1.002 ± 0.025 2−ΔΔCt, n = 7; Novel/Vehicle 0.863 ± 0.017 2−ΔΔCt, n = 10; Novel/SCH 0.968 ± 0.024 2−ΔΔCt, n = 10; Novel/Eticlopride 0.886 ± 0.010 2−ΔΔCt, n = 5; one-way ANOVA, F(3,28) = 8.751, p = 0.0003; Tukey's multiple comparisons test, Familiar vs Novel/Vehicle, p = 0.0007; Familiar vs Novel/SCH, p = 0.7041; Familiar vs Novel/Eticlopride, p = 0.0207; Novel/Vehicle vs Novel/SCH, p = 0.0047; Novel/Vehicle vs Novel/Eticlopride, p = 0.9056; Novel/SCH vs Novel/Eticlopride, p = 0.1088). d, miR-182 expression levels were significantly elevated following novel cage exposure, in mice receiving vehicle compared with SCH or familiar cage controls (Familiar 1.112 ± 0.131 2−ΔΔCt, n = 13; Novel/Vehicle 2.053 ± 0.361 2−ΔΔCt, n = 5; Novel/SCH 0.750 ± 0.214 2−ΔΔCt, n = 6; Kruskal–Wallis test, p = 0.0084; Dunn's multiple comparisons test, Familiar vs Novel/Vehicle, p = 0.0473; Familiar vs Novel/SCH, p = 0.773; Novel/Vehicle vs Novel/SCH, p = 0.0076). e, DAT-Cre mice injected with Cre-dependent hM4Di in LC that received vehicle, and mice injected with Cre-dependent mCherry that received CNO both showed a decrease in QR2 mRNA following novel cage exposure, but those expressing hM4Di that received CNO did not, compared with those that were kept in their home cages (Familiar 1.004 ± 0.039 2−ΔΔCt, n = 6; Novel/hM4Di + Vehicle 0.845 ± 0.044 2−ΔΔCt, n = 6; Novel/hM4Di + CNO 0.925 ± 0.032−ΔΔCt, n = 6; Novel/mCherry + CNO 0.749 ± 0.028, n = 5; one-way ANOVA, F(3,19) = 8.091, p = 0.0011; Tukey's multiple comparisons test, Familiar vs Novel/Vehicle, p = 0.0294; Familiar vs Novel/CNO, p = 0.3553; Novel/Vehicle vs Novel/CNO, p = 0.3408). f, Representative image of LC dopaminergic neurons, expressing hM4Di inhibitory DREADD. Data are mean ± SEM. *p < 0.05. **p < 0.01. ***p < 0.001. ****p < 0.0001.
Article Snippet: Transient cotransfection of four endotoxin-free plasmids (Endo Free plasmid Maxi kit, catalog #12362, QIAGEN) in HEK293FT (Invitrogen) cells produced self-inactivating, third-generation HIV-1-based viral vectors ( Tiscornia et al., 2006 ). pLenti-miR182-GFP and pLenti-control-GFP, as well as short
Techniques: Expressing, Injection, Control
Journal: The Journal of Neuroscience
Article Title: Dopamine-Dependent QR2 Pathway Activation in CA1 Interneurons Enhances Novel Memory Formation
doi: 10.1523/JNEUROSCI.1243-20.2020
Figure Lengend Snippet: Reduced QR2 expression in inhibitory interneurons improves novel object memory. a, A representative image of the mouse dorsal hippocampus using RNAscope probes to mark excitatory (vGlut) and inhibitory (GAD) neurons, as well as QR2 mRNA. Cell nuclei were stained with DAPI. QR2 was quantified by mean density per cell area, denoted by masks based on GAD, vGlut, and DAPI. b, QR2 mRNA was significantly reduced in CA1 of mice that underwent novel context exposure (Familiar 1 ± 0.019 AU, n = 2755 cells from n = 4 mice; Novel 0.729 ± 0.011 AU, n = 5301 cells from n = 4 mice; Mann–Whitney test, p < 0.0001). c, QR2 mRNA was unchanged in the auditory cortex control area (Familiar 1 ± 0.018 AU, n = 2751 cells from n = 4 mice; Novel 0.949 ± 0.016 AU, n = 2452 cells from n = 4 mice; Mann–Whitney test, p = 0.7002). d, Inhibitory neurons display significantly higher levels of QR2 compared with excitatory neurons (Inhibitory 1 ± 0.017 AU, n = 2714 cells from n = 4 mice; Excitatory 0.381 ± 0.005 AU, n = 5342 cells from n = 4 mice; Mann–Whitney test, p < 0.0001). e, Of the total reduction in QR2 mRNA seen following novel context exposure, 15.6% was from inhibitory and 11.9% from excitatory neurons. f, From the total QR2 signal measured, 57% was from inhibitory and 43% was from excitatory neurons. g, Cre-dependent QR2 shRNA virus was injected to GAD Cre mice, or coinjected to WT mice along with CamKII promoter expressed Cre, to CA1. h, Mice were exposed to an open field box and left to explore for 10 min. The following day, two identical objects were placed within the box, and the mice were allowed to explore for 10 min. The next day, one of the objects was replaced with a novel object, and the mice were given 10 min to explore. A discrimination index was then calculated. i, Mice that were injected with a lentivirus generally expressing shRNA targeting QR2 in neurons showed a significant improvement in discrimination compared with uninjected WT (red dashed line) or scrambled control animals (total exploration time of objects, Scrambled 68.12 ± 26.87 s; QR2 shRNA 40.25 ± 19.39 s; WT 70.17 ± 25.74 s; object discrimination, Scrambled −0.267 ± 0.114 DI, n = 5; QR2 shRNA 0.117 ± 0.040 DI, n = 6; WT −0.202 ± 0.0829 DI, n = 5; one-way ANOVA, F(2,13) = 6.939, p = 0.0089; Tukey's multiple comparisons test, Scrambled vs QR2 shRNA, p = 0.0116; Scrambled vs WT, p = 0.844; QR2 shRNA vs WT, p = 0.0341). j, GAD Cre mice injected with Cre-dependent shRNA targeting QR2 showed a significant improvement in discrimination compared with uninjected WT (red dashed line) or scrambled control animals (total exploration time of objects, GAD Cre-Scrambled 58.42 ± 16.52 s; GAD Cre-QR2 shRNA 43.06 ± 14.21 s; WT 70.17 ± 25.74 s; object discrimination, GAD Cre-Scrambled −0.147 ± 0.090 DI, n = 8; GAD Cre-QR2 shRNA 0.167 ± 0.058 DI, n = 9; WT −0.202 ± 0.0829 DI, n = 5; one-way ANOVA, F(2,19) = 6.856, p = 0.0057; Tukey's multiple comparisons test, GAD Cre-Scrambled vs GAD Cre-QR2 shRNA, p = 0.0165; GAD Cre-Scrambled vs WT, p = 0.891; GAD Cre-QR2 shRNA vs WT, p = 0.0141). k, Mice injected with Cre-expressing virus under the CamKII promoter and simultaneously with Cre-dependent shRNA targeting QR2 in CA1 showed no difference in NOR compared with uninjected WT (red dashed line) or scrambled control animals (total exploration time of objects CamKII Cre-Scrambled 23.26 ± 13.2 s; CamKII Cre-QR2 shRNA 106.5 ± 22.91 s; WT 70.17 ± 25.74 s; object discrimination, CamKII Cre-Scrambled −0.386 ± 0.074 DI, n = 7; CamKII Cre-QR2 shRNA −0.414 ± 0.105 DI, n = 8; WT −0.202 ± 0.0829 DI, n = 5; one-way ANOVA, F(2,17) = 1.295, p = 0.2995; Tukey's multiple comparisons test, CamKII Cre-Scrambled vs CamKII Cre-QR2 shRNA, p = 0.9734; CamKII Cre-Scrambled vs WT, p = 0.4134; CamKII Cre-QR2 shRNA vs WT, p = 0.2988). l, Mice injected with QR2 shRNA showed significantly reduced QR2 mRNA levels in CA1 compared with scrambled controls (Scrambled 1.01 ± 0.069 2-ΔΔCt, n = 5; QR2 shRNA 0.796 ± 0.022 2-ΔΔCt, n = 6; Student's t test, t = 3.172, df = 9, p = 0.0113). m, GAD Cre mice injected with Cre-dependent QR2 shRNA showed significantly lower QR2 mRNA levels in CA1 compared with scrambled controls (Scrambled 1.005 ± 0.050 2-ΔΔCt, n = 5; QR2 shRNA 0.850 ± 0.028 2-ΔΔCt, n = 8; Student's t test, t = 2.924, df = 11, p = 0.0138). n, Mice injected with a Cre-expressing virus under the CamKII promoter and simultaneously with Cre-dependent shRNA targeting QR2 in CA1 showed an insignificant reduction in QR2 expression in CA1 (Scrambled 1.096 ± 0.229 2-ΔΔCt, n = 6; QR2 shRNA 0.895 ± 0.046 2-ΔΔCt, n = 6; Student's t test, t = 0.8561, df = 10, p = 0.4120). Data are mean ± SEM. #p < 0.05 versus WT. *p < 0.05. ****p < 0.0001.
Article Snippet: Transient cotransfection of four endotoxin-free plasmids (Endo Free plasmid Maxi kit, catalog #12362, QIAGEN) in HEK293FT (Invitrogen) cells produced self-inactivating, third-generation HIV-1-based viral vectors ( Tiscornia et al., 2006 ). pLenti-miR182-GFP and pLenti-control-GFP, as well as short
Techniques: Expressing, RNAscope, Staining, MANN-WHITNEY, Control, shRNA, Virus, Injection
Journal: The Journal of Neuroscience
Article Title: Dopamine-Dependent QR2 Pathway Activation in CA1 Interneurons Enhances Novel Memory Formation
doi: 10.1523/JNEUROSCI.1243-20.2020
Figure Lengend Snippet: Inhibitory, but not excitatory, neurons hyperpolarize and show reduced excitability following intracellular QR2 inhibition. a, Excitatory cells in CA1 show no change in firing rate on intracellular application of QR2 inhibitor S29434 (two-way repeated-measures ANOVA, Pulse F(7,315) = 346.3, p < 0.0001; Treatment F(1,45) = 0.5107, p = 0.4785; Interaction F(7,315) = 0.3242, p = 0.9428). b, Representative traces recorded from excitatory neurons in CA1. c, Resting membrane potential in unchanged in excitatory neurons of CA1 on the intracellular application of QR2 inhibitor S29434 (Vehicle −60.86 ± 0.6677 mV, n = 27 cells, n = 6 mice; S29434 0.5 μm −61.24 ± 0.8514 mV, n = 20 cells, n = 4 mice; Student's t test, t = 0.3569, df = 45, p = 0.7228). d, GAD-Cre mice were injected to CA1 with Cre-dependent mCherry. Inhibitory neurons are seen in red. e, Inhibitory cells in CA1 show a significant reduction in firing rate on intracellular application of QR2 inhibitor S29434 (two-way repeated-measures ANOVA, Pulse F(7,140) = 45.45, p < 0.0001; Treatment F(1,20) = 11.74, p = 0.0027; Interaction F(7,140) = 2.533, p = 0.0175; Sidak's multiple comparisons test of Vehicle vs S29434 0.5 μm at 50 pA, p = 0.9799; 100 pA, p = 0.3018; 150 pA, p = 0.2318; 200 pA, p = 0.3369; 250 pA, p = 0.2105; 300 pA, p = 0.0197; 350 pA, p = 0.0022; 400 pA, p = 0.0001). f, Representative traces recorded from inhibitory neurons in CA1. g, Resting membrane potential of inhibitory neurons in CA1 is significantly hyperpolarized on the intracellular application of QR2 inhibitor S29434 (Vehicle −52.83 ± 1.56 mV, n = 10 cells, n = 5 mice; S29434 0.5 μm −61.24 ± 2.275 mV, n = 12 cells, n = 5 mice; Student's t test, t = 2.841, df = 20, p = 0.0.0101). h, S29434 intracellular application does not alter excitatory cell rheobase (Vehicle 158.8 ± 10.94 ms, n = 23 cells, n = 6 mice; S29434 0.5 μm 139.3 ± 10.02 ms, n = 20 cells, n = 4 mice; Student's t test, t = 1.305, df = 41, p = 0.1991). i, S29434 intracellular application significantly increases inhibitory cell rheobase (Vehicle 47.1 ± 7.96 ms, n = 10 cells, n = 5 mice; S29434 0.5 μm 78.92 ± 9.017 ms, n = 12 cells, n = 5 mice; Student's t test, t = 2.592, df = 20, p = 0.0174). Data are mean ± SEM. *p < 0.05. **p < 0.01. ***p < 0.001. Traces are scaled at 100 ms, 20 mV from 350 pA step.
Article Snippet: Transient cotransfection of four endotoxin-free plasmids (Endo Free plasmid Maxi kit, catalog #12362, QIAGEN) in HEK293FT (Invitrogen) cells produced self-inactivating, third-generation HIV-1-based viral vectors ( Tiscornia et al., 2006 ). pLenti-miR182-GFP and pLenti-control-GFP, as well as short
Techniques: Inhibition, Membrane, Injection
Journal: The Journal of Neuroscience
Article Title: Dopamine-Dependent QR2 Pathway Activation in CA1 Interneurons Enhances Novel Memory Formation
doi: 10.1523/JNEUROSCI.1243-20.2020
Figure Lengend Snippet: Dysregulation of QR2 and miR-182 is correlated to increased oxidation in aged mouse hippocampus. a, QR2 mRNA expression is elevated in CA1 of aged compared with young adult mice (3-month-old 1.002 ± 0.029 2-ΔΔCt, n = 5; 20-month-old 1.092 ± 0.019 2-ΔΔCt, n = 5; Student's t test, t = 2.55, df = 8, p = 0.0341). b, miR-182 expression is reduced in CA1 of aged compared with young adult mice (3-month-old 1.014 ± 0.084 2-ΔΔCt, n = 5; 20-month-old 0.463 ± 0.201 2-ΔΔCt, n = 5; Student's t test, t = 2.526, df = 8, p = 0.0355). c, Kv2.1 semi-native blot, following nonreducing SDS-PAGE. Top, Oligomeric, oxidized Kv2.1 channels. Bottom, Functional monomers. Y = 3-month-old, A = 20-month-old. d, Aged, 20-month-old mice show an increase in oxidized and thus oligomerized Kv2.1 channels compared with young, 3-month-old mice (3-month-old 1.479 ± 0.055 AU, n = 5; 20-month-old 1.878 ± 0.146 AU, n = 5; Student's t test, t = 2.541, df = 8, p = 0.0347). e, Total Kv2.1 and actin from the same samples previously shown in their native state, following reduction and boiling. Y = 3-month-old, A = 20-month-old. f, No difference is seen in the expression levels of Kv2.1 in 20-month-old mice compared with 3-month-old mice (3-month-old 0.5979 ± 0.061 AU, n = 5; 20-month-old 0.549 ± 0.034 AU, n = 5; Student's t test, t = 0.6882, df = 8, p = 0.5108). Data are mean ± SEM. *p < 0.05.
Article Snippet: Transient cotransfection of four endotoxin-free plasmids (Endo Free plasmid Maxi kit, catalog #12362, QIAGEN) in HEK293FT (Invitrogen) cells produced self-inactivating, third-generation HIV-1-based viral vectors ( Tiscornia et al., 2006 ). pLenti-miR182-GFP and pLenti-control-GFP, as well as short
Techniques: Expressing, SDS Page, Functional Assay
Journal: The Journal of Neuroscience
Article Title: Dopamine-Dependent QR2 Pathway Activation in CA1 Interneurons Enhances Novel Memory Formation
doi: 10.1523/JNEUROSCI.1243-20.2020
Figure Lengend Snippet: A previously undescribed D1R-dependent pathway in CA1 during novel memory formation, which results in reduced interneuron excitability is mediated by QR2 suppression. Following novel environmental learning, both immediate and long-term molecular and cellular mechanisms have been described (green) that lead to long-term memory formation. Alongside these mechanisms, and entrained by dopaminergic input from the LC to the hippocampus, miR-182 is upregulated and suppresses QR2 expression. QR2 suppression in the brain leads to reduced ROS (Gould et al., 2020), which in CA1 occurs within inhibitory interneurons 3 h following a novel contextual experience. The reduction in QR2 leads to hyperpolarization and reduced firing of inhibitory interneurons in CA1, which enhances memory facilitation (Makkar et al., 2010).
Article Snippet: Transient cotransfection of four endotoxin-free plasmids (Endo Free plasmid Maxi kit, catalog #12362, QIAGEN) in HEK293FT (Invitrogen) cells produced self-inactivating, third-generation HIV-1-based viral vectors ( Tiscornia et al., 2006 ). pLenti-miR182-GFP and pLenti-control-GFP, as well as short
Techniques: Expressing